Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9597)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2018 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol 2018; 24(12): 1321-1331 [PMID: 29599607 DOI: 10.3748/wjg.v24.i12.1321] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i12/1321.htm |
| Number | Citing Articles |
| 1 |
Brian I. Shaw, Aaron Lucander, Kadiyala V. Ravindra. Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and Management. Transplantation Direct 2019; 5(9): e483 doi: 10.1097/TXD.0000000000000921
|
| 2 |
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Jai Patel, Mina Hibino, Ian Carmody, Ari J. Cohen, Paul Thevenot. Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers 2021; 13(19): 4765 doi: 10.3390/cancers13194765
|
| 3 |
Lei Cao, Hongwei Cheng, Qiuxia Jiang, Hui Li, Zhixian Wu. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging 2020; 12(5): 4573 doi: 10.18632/aging.102913
|
| 4 |
Nicha Wongjarupong, Gabriela M. Negron-Ocasio, Kristin C. Mara, Kritika Prasai, Mohamed A. Abdallah, Keun Soo Ahn, Ju Dong Yang, Benyam D. Addissie, Nasra H. Giama, William S. Harmsen, Terry M. Therneau, Lewis R. Roberts. BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort study. HPB 2021; 23(5): 762 doi: 10.1016/j.hpb.2020.09.014
|
| 5 |
Sang Eun Ha, Anjugam Paramanantham, Hun Hwan Kim, Pritam Bhagwan Bhosale, Min Yeong Park, Abuyaseer Abusaliya, Jeong Doo Heo, Won Sup Lee, Gon Sup Kim. Comprehensive transcriptomic profiling of liver cancer identifies that histone and PTEN are major regulators of SCU‑induced antitumor activity. Oncology Letters 2024; 27(3) doi: 10.3892/ol.2024.14227
|
| 6 |
Chenjun Huang, Meng Fang, Xiao Xiao, Hong Wang, Zhiyuan Gao, Jun Ji, Lijuan Liu, Erli Gu, Ya Li, Mengmeng Wang, Chunfang Gao. Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study. Liver International 2022; 42(1): 210 doi: 10.1111/liv.15082
|
| 7 |
Kai Wang, Libin Dong, Qian Lu, Zhe Yang, Xiaoli Fan, Fengqiang Gao, Wenwen Ge, Zhoucheng Wang, Zhisheng Zhou, Di Lu, Xuyong Wei, Qiang Wei, Li Zhuang, Lunxiu Qin, Qifa Ye, Jiayin Yang, Jiahong Dong, Shusen Zheng, Xiao Xu. Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: A multi-center retrospective cohort study in China. International Journal of Surgery 2023; doi: 10.1097/JS9.0000000000000729
|
| 8 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 9 |
Osama Makhamrah, Muntaser S. Ahmad, Mohammad Hjouj. Evaluation of Liver Phantom for Testing of the Detectability Multimodal for Hepatocellular Carcinoma. Proceedings of the 2019 2nd International Conference on Digital Medicine and Image Processing 2019; : 17 doi: 10.1145/3379299.3379307
|
| 10 |
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot. α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk. Gastro Hep Advances 2024; 3(3): 316 doi: 10.1016/j.gastha.2023.11.018
|
| 11 |
Zheyu Zhou, Qiaoyu Liu, Jinsong Liu, Wenwen Li, Shuya Cao, Jiawei Xu, Jun Chen, Xiaoliang Xu, Chaobo Chen. Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma. Heliyon 2024; 10(9): e30622 doi: 10.1016/j.heliyon.2024.e30622
|
| 12 |
Haoran Jiang, Xianxin Wen, Xue Zhang, Xianhua Zhong, Zhangyong Li, Bingyu Zhang. Lens culinaris agglutinin inhibits human hepatoma cell migration via mannose and fucose-mediated ERK1/2 and JNK1/2/3 signalling pathway. Molecular Biology Reports 2022; 49(8): 7665 doi: 10.1007/s11033-022-07582-z
|
| 13 |
Ping Chen, Haolin Song, Wei Xu, Jin Guo, Jianfei Wang, Juhong Zhou, Xiang Kang, Chaolei Jin, Yubo Cai, Zixuan Feng, Hainv Gao, Fengmin Lu, Lanjuan Li. Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1037742
|
| 14 |
Vincent L. Chen, Pratima Sharma. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 577 doi: 10.1016/j.cld.2020.07.001
|
| 15 |
Yang Yang, Guangbing Li, Ziwen Lu, Yong Liu, Junjie Kong, Jun Liu. Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.726213
|